Preemployment screening for tuberculosis in a large health care setting: Comparison of the tuberculin skin test and a whole-blood interferon-γ release assay

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 3, 2011, Pages 290-293

  Khoury, Nicole Zitterkopf ^a   Binnicker, Matthew J ^b   Wengenack, Nancy L ^b   Aksamit, Timothy R ^b   Buchta, William G ^b   Molella, Robin G ^b  

^a Oklahoma State Department   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; TUBERCULIN;

ARTICLE; BCG VACCINATION; BLOOD; CYTOKINE RELEASE; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; HEALTH SURVEY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OCCUPATIONAL HEALTH SERVICE; PREEMPLOYMENT MEDICAL EXAMINATION; PREVALENCE; QUANTIFERON TB GOLD TEST; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

EID: 79953049200     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31820c91c5     Document Type: Article

References (25)

1. World Health Organization. Tuberculosis facts. Available at: http://www.who.int/tb/publications/2009/tbfactsheet2009updateonepage.pdf. Accessed December 8, 2009.
2. Cohn DL. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49:1-54. Available at: http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr4906a1.htm.
3. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49:1-51.
4. de Vries G, Sebek MMGG, Lambregts-van Weezenbeek CSB. Healthcare workers with tuberculosis infected during work. Eur Respir J. 2006;28: 1216-1221.
5. Maloney SA, et al. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and healthcare workers. Ann Intern Med. 2005;122:90-95.
6. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49: 1-54.
7. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis, in Health-care settings.MMWR Recomm Rep. 2005;54:10-18.
8. Dheda K, Van Zyl Smit R, Badri M, Pai M. T-cell interferon-g release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low burden settings. Curr Opin Pulm Med. 2009;15:188-200.
9. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2010;59:11-12.
10. Health Protection Agency. Position Statement on the use of Interferon Gamma Assay (IGRA) test for tuberculosis (TB). Draft interim HPA guidance HPA tuberculosis programme board. Available at: http://www.hpa.org.uk/web/ HPAwebFile/HPAweb C/1204186168242. Accessed December 8, 2009.
11. National Institute for Health and Clinical Excellence. Clinical Guideline 33, Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Available at: http://guidance.nice.org. uk/CG33/NiceGuidance/pdf/English. Published 2006. Accessed December 8, 2009.
12. Canadian Tuberculosis Committee. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2008;34:1-13.
13. Zwerling A, Behr M, Verma A, Brewer T, Menzies D, Pai M. World Atlas of BCG Policies and Practices. Available at: http://www.bcgatlas.org/. Accessed July 23, 2010.
14. Jong LK, Ae KY, Mi KY, Cho S, Wook MJ. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-γ assay. Scand J Infect Dis. 2010;42: 672-678.
15. Diel R, Loddenkemper R, Niemann S, et al. Negative and positive predictive value of a whole-blood IGRA for developing active TB\an update. Am J Respir Crit Care Med. 2011;183:88-95.
16. Kik SV, Franken WPJ, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J. 2010;35:1346-1353.
17. Pooran A, Booth H, Robert F, et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulmon Med. 2010;10:7.
18. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood IGRA for developing active TB\an update [published online ahead of print August 27, 2010]. Am J Respir Crit Care Med. 2010; doi: 10.1164/rccm. 201006-0974OC.
19. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-γ release assays for detecting active TB. Chest. 2010;137:952-968.
20. Yoshiyama T, Harada N, Higuchi K, Sekiya Y, Uchimura K. Use of the Quanti FERON-TB Gold test for screening tuberculosis contacts and predicting active disease. Int J Tuberc Lung Dis. 2010;14:819-827.
21. Marra F, Marra CA, Sadatsafavi M, et al. Cost-effectiveness of a new interferon-based blood assay, Quanti FERON-TB Gold, in screening tuberculosis contacts. Int J Tuberc Lung Dis. 2008;12:1414-1424.
22. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening. Int J Tuberc Lung Dis. 2007;11:16-26.
23. Schwartzman K, Menzies D. Tuberculosis screening of immigrants. Am J Respir Crit Care Med. 2000;161:780-789.
24. Kik SV, Franken WPJ, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts [published online ahead of print 2009]. Eur Respir J. 2010;35:1346-1353;, doi: 10.1183/09031936.00098509.
25. Pai M, Menzies D. The new IGRA and the old TST: making good use of disagreement. Am J Respir Crit Care Med. 2007;175:529-531. (Pubitemid 46438935)